MRP ₹355.31
₹284.25
₹25.38/Units
Use current location
Login to view saved addresses
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
CompositionTiare 90 Tablet is used in reducing the risk of cardiovascular events such as heart attack and stroke by preventing harmful blood clots. It belongs to the platelet aggregation inhibitor class.
It is also used to prevent clot formation after stent placement and is beneficial for patients with a history of myocardial infarction or acute coronary syndrome to prevent recurrence.
Tiare 90 Tablet is used to reduce the risk of heart attack and manage acute coronary syndrome in adults. It prevents blood clot formation, supports smoother blood flow, and lowers the chances of cardiovascular death. Doctors also recommend it after stent placement to prevent clot-related complications and ensure long-term heart protection.
Here's how to use Tiare 90 Tablet:
Swallow the tablet whole with a full glass of water.
Do not chew or crush the tablet.
Always stick to the dosage instructions provided by your doctor.
Tiare 90 Tablet is taken orally.
Tiare 90 Tablet may cause side effects like bleeding, shortness of breath (dyspnoea), headache, dizziness, nausea, vomiting, diarrhoea, constipation, rash, and itching. Consult your doctor if these symptoms become severe.
Most side effects are temporary and generally harmless, which resolve on discontinuing the use of Tiare 90 Tablet. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor.
Here are some general guidelines for managing common side effects:
Diarrhoea: Consume plenty of water and healthy fluids to avoid dehydration.
Nausea and vomiting: Consider taking this medicine after meals to lessen this effect.
Tiare 90 Tablet contains Ticagrelor (90 mg). This active ingredient works in the body in the following ways:
P2Y12 Receptor Antagonist: Ticagrelor directly and reversibly blocks the P2Y12 receptor on the surface of platelets. This receptor is activated by adenosine diphosphate (ADP), a substance that makes the platelets stick together, forming clots.
Reduces Platelet Aggregation: By blocking the P2Y12 receptor, ticagrelor prevents ADP from activating another important component on the platelet surface, the GPIIb/IIIa receptor complex. This action reduces the ability of platelets to stick together, thereby decreasing the formation of harmful blood clots in the blood vessels.
Caution is advised while taking Tiare 90 Tablet if you are pregnant. It is best to consult your doctor before taking this medicine.
Tiare 90 Tablet is contraindicated for breastfeeding/lactating women. Consult your doctor to understand the potential risks and benefits.
It's prudent to limit alcohol consumption during its use. Consult your doctor for guidance.
Caution is advised while taking Tiare 90 Tablet in case of mild to moderate liver impairment. This medicine is not recommended if you have severe liver disease. Discuss your liver health with your doctor before
Caution is advised before using Tiare 90 Tablet if you have a history of kidney problems. Consult your doctor before taking this medicine.
Tiare 90 Tablet may cause dizziness. If you experience this, avoid driving or operating heavy machinery until the effects subside.
Avoid using this medicine if you are allergic to ticagrelor or any other ingredients of Tiare 90 Tablet. Inform your doctor about your allergies.
Children under 18 years should only take Tiare 90 Tablet under medical supervision. Always consult with a doctor before giving any medicine to a child.
Older patients should take Tiare 90 Tablet under medical supervision, as they may be more susceptible to its side effects. Your doctor will guide you based on your health status.
Tiare 90 Tablet interacts with the following medicines:
Strong CYP3A Inhibitors: Medications such as ketoconazole, clarithromycin, and nefazodone can increase the levels of Ticagrelor in the body, thereby increasing the risk of bleeding.
Strong CYP3A Inducers: Medicines like rifampin, phenytoin, and carbamazepine may decrease the effectiveness of Tiare 90 Tablet, as they accelerate its metabolism.
Aspirin and Other NSAIDs: When taken with this medicine, NSAIDs like ibuprofen can enhance the risk of bleeding.
Opioids: These medicines can delay and reduce the absorption of Ticagrelor, potentially reducing its effect.
Simvastatin and Lovastatin (doses >40 mg): These medicines may increase the risk of muscle disorders when taken with Tiare 90 Tablet.
Digoxin: It may increase the risk of abnormal heart rhythms when taken alongside this medication.
Grapefruit and grapefruit juice may increase levels of ticagrelor in your body. This can increase your chance of getting side effects.
Tiare 90 Tablet interacts with the following diseases:
Active Pathological Bleeding: This medicine can exacerbate bleeding in patients with active pathological bleeding conditions like haemophilia or peptic ulcers.
History of Intracranial Haemorrhage: Patients with a history of intracranial haemorrhage should avoid this medication as it might increase the risk of bleeding.
Severe Hepatic Impairment: This tablet should be used cautiously in patients with severe hepatic impairment due to reduced metabolism and increased risk of adverse effects.
The daily dose of Tiare 90 Tablet should be as directed by your doctor. The dosage may be altered based on individual factors such as the severity of your condition and how you respond to the medication. It's crucial to stick to your prescribed dose and not to exceed it without consulting your doctor.
If you accidentally take more than the prescribed dose of Tiare 90 Tablet, you might experience side effects like dizziness or a headache. In such cases, inform your doctor about the situation.
If you forget to take a dose of Tiare 90 Tablet, take it as soon as you remember. But if it's nearly time for your next dose, skip the one you missed and continue your regular schedule. Don't increase your dosage without talking to your doctor.
Always store your Tiare 90 Tablet at room temperature, ideally not exceeding 30°C.
Protect the medicine from excessive light and moisture; maintain its original packaging.
Keep the medicine out of reach of children to prevent accidental consumption.
Use the medicine before its expiry date for optimal results.
Heart health is vital, so include foods rich in omega-3 fatty acids, such as fish, walnuts, and flaxseeds, in your diet. These help manage cardiovascular risks associated with acute coronary syndrome or a history of myocardial infarction.
Regular moderate exercise, like a brisk walk or cycling, can help manage your heart conditions better. However, always consult your doctor before starting a new exercise regime.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Acute Coronary Syndrome, Myocardial Infarction, Stent Clot Prevention |
| Drug Category | P2Y12 Receptor Antagonist |
| Therapeutic Category | Antiplatelet Agent |
It's a medicine containing 90 mg of ticagrelor, an antiplatelet agent that helps prevent harmful blood clot formation in blood vessels.
This medicine is primarily used to manage the risk of heart attacks, strokes, and cardiovascular death in patients with acute coronary syndrome or heart attack history.
Ticagrelor, the active ingredient, prevents platelets in your blood from sticking together, reducing the possibility of dangerous blood clot formation.
Common side effects include bleeding, shortness of breath, headache, dizziness, nausea, vomiting, diarrhoea, constipation and skin rash. If symptoms persist, consult your doctor.
No, it's not suitable for patients with active bleeding, a history of brain haemorrhage or severe liver failure. Always consult your doctor before starting any medication.
Yes, it interacts with certain medicines, such as CYP3A inhibitors or inducers, aspirin, and other NSAIDs. Always inform your doctor about all medicines you're currently taking.
Store this medicine at room temperature (under 30°C), in a tightly closed container away from moisture and light. Keep it out of children's reach.
Check out Editorial Policy
NHS UK. (n.d.). Ticagrelor (including Brilique). https://www.nhs.uk/medicines/ticagrelor/. Accessed 1 April 2024.
U.S. Food and Drug Administration. (2015). NDA 22-433/S-013 Approval Letter. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022433Orig1s013ltr.pdf. Accessed 1 April 2024.
Ticagrelor: MedlinePlus drug information. (2021, January 15). MedlinePlus - Health Information from the National Library of Medicine. https://medlineplus.gov/druginfo/meds/a611050.html
Ticagrelor. (2024, October 13). DrugBank Online | Database for Drug and Drug Target Info. https://go.drugbank.com/drugs/DB08816
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
50.1% CHEAPER
19054 users bought this instead
Read More
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesDiseases & Health ConditionsAyurvedaAll MedicinesAll BrandsNeed HelpFAQSecuritySubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.8.1
2025 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
